Vascular Endothelial Growth Factor Industry Trends and Key Insights by 2024
Vascular endothelial growth factor (VEGF) is an endothelial cell-specific mitogen that stimulates the proliferation, migration and survival of endothelial cells. The human VEGF family consists of five ligands, namely, VEGF (or VEGF-A), VEGF-B VEGF-D VEGF-D and placental growth factor. Vascular endothelial growth factor is involved in several pathophysiological processes and is therefore a popular approach for developing therapies to treat related diseases such as cancers and macular degeneration. The market for VEGF antibodies is gaining traction since it offers several...
View full press release